
Zayatta Investment specializes in deploying its own capital in targeted investments within the healthcare industry. Our approach is driven by a commitment to selecting companies that are leaders in their fields and have the potential to deliver substantial returns through innovation and excellence. We focus on:
Targeting companies that are developing breakthrough health technologies.
Supporting the advancement of scientifically-backed multivitamins, food supplements, and functional food ingredients.
Developing producers of high-quality organic and conventional infant formulas.
Backing firms that create specialized nutrition products for medical and clinical use.
Focusing on companies involved in the development of biological and biosimilar pharmaceuticals, as well as value-added medicines.
Our investment philosophy reflects our belief that “Investing in innovation is investing in the future of health.” This philosophy guides us as we explore new opportunities in Saudi Arabia, where the Vision 2030 initiative is opening up unparalleled prospects for growth and innovation. By channeling our financial strength into companies that share our vision, we ensure that our investments contribute to meaningful advancements in the healthcare sector.